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1. Introduction 
Diabetes mellitus is the most common serious metabolic disorder in the world. Diabetes is 
characterized by a hyperglycemia that results from an absolute or relative insulin deficiency 
and is associated with long term complications affecting the eyes, kidneys, heart and nerves 
(Baydas et al., 2003). Oxidative stress is defined as imbalance between the generation of 
reactive oxygen species and antioxidant defense capacity of the body that is closely 
associated with aging and a number of diseases including cancer, cardiovascular diseases, 
diabetes and diabetic complications (Atalay et al., 2002). Irregular cellular metabolism in 
diabetes leads to production of free oxygen radicals and imbalanced antioxidant capacity 
(oxidative stress) of the body (Vincent et al., 2004). 
Recent studies have shown that both types of diabetes can increase oxidative stress in blood 
and treatment with antioxidants such as vitamin E and flavonoids may be used for 
decreasing of oxidative stress and diabetic complications (Baydas et al., 2003; Vincent et al., 
2004). There is good evidence that tea flavonoids intake have a role in protection against 
degenerative diseases and long-term intake of tea flavonoids can prevent obesity in high fat 
diet. Also it has positive effects against glucose metabolism disorders and diabetes-induced 
fat disorders that lead to lowering the risk of diabetes complications (Crespy et al., 2004). 
Flavonoids have antioxidant properties, and tea is one of the main sources of flavonoids. 
Tea (from the plant Camellia Sinensis) is the most popular beverage next to water, 
consumed by over two-thirds of the world’s population. About three billion kilograms of tea 
are produced and consumed yearly (Yang, 2000; Gupta et al., 2002; Crespy et al., 2004). 
Regular intake of tea is associated with an improved antioxidant status in vivo conditions 
that may contribute to the lowering risk of certain types of cancer, coronary heart disease, 
atherosclerosis, stroke, reduced mutagenicity and inflammation, protection against 
neurodegenerative diseases and increasing insulin sensitivity (Luximon-Ramma et al., 2005; 
Alipoor et al., 2011). 
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2. Diabetes 
Diabetes resembles fasting, especially regarding the responses of the liver, muscle cells, and 
adipose tissues. With low serum ratios of insulin to glucagon and high levels of fatty acids, 
the liver produces glucose, whereas other tissues use fatty acids and ketones instead of 
glucose. Muscle cells and adipose tissue respond by using ketones and fatty acids. Although 
these resemblances between fasting and diabetes are striking, pathologically low serum 
insulin levels disrupt the efficiency seen during fasting. With low insulin levels, key 
glycolytic enzyme activities decrease. Glucose use decreases to levels far below those seen 
during fasting. Concurrently, hepatic gluconeogenic enzyme activities and gluconeogenic 
rates increase.Bombarded with free fatty acids, the liver increases gluconeogenesis, secreting 
large amounts of very low density lipoproteins (VLDLs) and accumulating fatty acids in 
droplet form. A long-term toxic effect of diabetes is the accumulation of 25% more lipid than 
normal. In the diabetic state, the liver oxidizes these fatty acids and produces acetone, 
acetoacetate, and ǃ-hydroxybutyrate. Muscle cells and adipose tissue also show major 
metabolic changes in diabetes. Muscle glycogen almost disappears, and muscle protein is 
broken down to support gluconeogenesis. Cardiac and skeletal muscles meet their energy 
needs from ketones and fatty acids. Fat cells actively release fatty acids under the lipolytic 
stimuli of glucagon, catecholamines, and insulin deficiency (Shils et al., 2006). 
2.1 Historical overview 
Diabetes mellitus is a chronic disease that has affected mankind throughout the world. The 
records of the ancient civilizations of Egypt, India, Japan, Greece, and Rome describe the 
symptoms of the disease and usually include recommendations for treatment. The wasting 
away of flesh, copious urination, and the sweet taste of the urine were frequently noted by 
the ancient medical writers. Aretaeus of Cappadocia, who lived between A.D. 30 and 90, not 
only named the disease diabetes, which means “to run through or to siphon” but also 
recommended, “The food is to be milk and with in the cereals, starch, autumn fruits and 
sweet wines”. The term mellitus, which means honey like, was added by a London 
physician, Willis, in 1675 (Robinson, 1972). 
2.2 Epidemiology and etiology 
Diabetes mellitus has reached epidemic proportions worldwide. There is an apparent 
epidemic of diabetes which is strongly related to lifestyle and economic change (WHO). 
Over the next decade the projected number will exceed 200 million. Most will have type2 
diabetes, and all are at risk of the development of complications. Diabetes mellitus is a 
heterogeneous group of diseases that develops dangerously and characterized by a state of 
chronic hyperglycemia, resulting from a diversity of etiologies, environmental and genetic. 
Diabetes mellitus is increasing due to population growth, aging, consequences of 
industrialization and urbanization, preference of high fat containing fast foods, sedentary 
life and obesity. Given the enormous public health and economic burden posed by the 
global epidemic of type 2 diabetes mellitus (T2DM), intervention in the pre-diabetes stage of 
disease to prevent progression to T2DM and its vascular complications seems the most 
sensible approach. Prudent lifestyle changes have been shown to significantly reduce the 
risk of progression in individuals with impaired fasting glucose (IFG) and impaired glucose 
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tolerance (IGT). Although lifestyle modifications are difficult to maintain, there is evidence 
that intensive intervention results in continued preventive benefit after the stopping of 
structured counseling (Bharati et al., 2011). 
The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 
and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 
million in 2000 to 366 million in 2030. Quantifying the prevalence of diabetes and the 
number of people affected by diabetes, now and in the future, is important to allow rational 
planning and allocation of resources (Wild et al., 2011). 
2.3 Classification and diagnosis 
Diabetes is a heterogeneous disorder both genetically and clinically and is hyperglycemia, 
attributable to either insulin insufficiency or insulin resistance. The traditional classification 
separates out hyperglycemic conditions into these groups: insulin-dependant diabetes 
mellitus (IDDM or type 1), non-insulin-dependent diabetes mellitus (NIDDM or type 2), 
other specific types of diabetes and gestational diabetes mellitus (GDM). Type 1 diabetes 
accounts for approximately 5% of diabetes and is manifested by insulin deficiency caused by 
destruction of the pancreatic ǃ cells. Type 2 diabetes accounts for about 90% of diabetes and 
is characterized by two primary defects: insulin resistance (diminished tissue sensitivity to 
insulin) and impaired ǃ-cell function (delayed or inadequate insulin release). Other causes 
account for the remaining 5% of diabetes. Classic symptoms such as polydipsia, polyuria, 
and rapid weight loss associated with gross and unequivocal elevation of blood glucose 
(≥200 mg/dl) make the diagnosis of Diabetes mellitus. A fasting plasma glucose level 
greater than or equal to 126 mg/dl on two occasions is diagnostic of diabetes (Shils et al., 
2006). 
2.4 Diabetic complication 
Associated to insulin-dependent diabetes (type 1), makes the disease one of the worst by 
considering the human suffering and the socio-economic trouble. In developed countries 
the number of diabetic patients is increasing all the time and both inability and mortality 
values are staggering. There is a dedication of studies aiming first to block or slow down 
the onset of type 1 diabetes, secondly to identify the numerous environmental and genetic 
factors causing type 2 diabetes and thirdly to suggest possible ways for the prevention or 
the postponement of crippling complications. The initial problem of diabetes is the 
hyperglycemia due to the inability of several control systems to maintain a normal 
glycemic plasma level. A first question is: can diabetic complications be prevented or 
delayed by normalizing hyperglycemia? This can be achieved at least in part if a 
meticulous control of glycemia is kept with an appropriate diet, oral anti-diabetic drugs, 
or insulin administration associated with daily exercise and a correct lifestyle. However, 
owing to genetic factors and in spite of a serious control, complications are found even in 
patients with a transitory and slight hyperglycemia. Circulatory abnormalities are the 
common denominator and they are present under the form of micro- and macro-vascular 
disease. Throughout the years the following complications may develop with different 
intensity and localization:  
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1. Diabetic retinopathy is a leading cause of blindness in about 85% of patients aged 20-75 
years.  
2. Diabetic nephropathy occurs in 20-40% of patients and when the GFR is <15 ml/min, 
the end stage renal disease (ESRD) is a leading cause of disability and premature death. 
3. Diabetic foot disease normally caused by several factors such as peripheral vascular 
disease (PVD), altered biomechanics, possibly polyneuropathy and infected foot ulcers. 
4. Neuropathy involving both the somatic and autonomic nervous system with 
neuromuscular dysfunction and muscular wasting is another major cause of morbidity.  
5. Accelerated atherosclerosis frequently manifests itself with myocardial infarction, 
stroke and limb vascular occlusion complicated with necrotic ulcers. 
6. Lipodistrophy, seemingly due to ineffective leptin activity or/and fatty acids 
dysmetabolism, represents another aspect of the metabolic syndrome (Bocci et al., 2011).  
Early detection and appropriate management of diabetes is essential to reduce major 
morbidity and mortality, however these strategies are not implemented in many countries 
of the world. In the diabetes centre in Isfahan, I.R. Iran, the rate of complications among 
approximately 4000 type 2 diabetes patients have been recorded as: ischemic heart disease 
34%, hypertension 50%, congestive heart failure 12%, retinopathy 44%, cataract 5%, 
bacteriuria 27%, nephropathy 19%, neuropathy 27%,depression 60%, diabetic foot 2.5%, 
hypercholesterolemia 37%, and hypertriglyceridemia 37%. Among 296 cases of non-
traumatic amputations, 38% were diabetes-related; 27% of stroke cases (cerebrovascular 
accident), 15% of patients with acute myocardial infarction and 15% of dialysis patients 
were also diabetics (Azizi et al., 2003). 
3. Oxidative stress 
Oxidative stress happens in a cellular system when the production of free radical moieties 
exceeds the antioxidant capacity of that system. If cellular antioxidants do not remove free 
radicals, radicals attack and damage proteins, lipids and nucleic acids. The oxidized or 
nitrosylated products of free radical attack have decreased biological activity, leading to loss 
of energy metabolism, cell signaling, transport, and other major functions. These altered 
products also are objected for proteosome degradation, further decreasing cellular function. 
Accumulation of such injury ultimately leads a cell to die through necrotic or apoptotic 
mechanisms (Vincent et al., 2004). 
3.1 Historical overview  
The presence of free radicals in biological materials was discovered less than 50 years ago. 
Thereafter, Denham Harman hypothesized that oxygen radicals may be formed as by-
products of enzymatic reactions in vivo. In 1956, he described free radicals as a Pandora’s 
Box of evils that may account for gross cellular damage, mutagenesis, cancer, and last but 
not least, the degenerative process of biological aging. The science of free radicals in living 
organisms entered a second time after McCord and Fridovich discovered the enzyme 
superoxide dismutase (SOD) and, finally convinced most colleagues that free radicals are 
important in biology. Numerous researchers were now inspired to investigate oxidative 
damage inflicted by radicals upon DNA, proteins, lipids, and other components of the cell. 
A third period began with the first reports describing advantageous biological effects of free 
radicals. Mittal and Murard provided suggestive evidence that the superoxide anion, 
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through its derivative, the hydroxyl radical, stimulates the activation of guanylate cyclase 
and formation of the “second messenger” cGMP. Similar effects were reported for the 
superoxide derivative hydrogen peroxide. It was discovered that nitric oxide (NO) has 
independently role as a regulatory molecule in the control of smooth muscle relaxation and 
in the inhibition of platelet adhesion (Droge, 2002).  
Also it is found that in activated T-cells the superoxide anion or low micromolar 
concentrations of hydrogen peroxide increase the production of the T-cell growth factor, 
interleukin-2 which is an immunologically important T-cell protein. Studies have shown 
that hydrogen peroxide induces the expression of the heme oxygenase (HO-1) gene and 
hydrogen peroxide has induction effects on various genes in bacteria, as well as activation of 
the transcription factor nuclear factor κB (NF-κB) in mammalian cells. At the beginning of 
the 21st century, there is a large amounts of evidence showing that living organisms have 
not only adapted to an unfriendly coexistence with free radicals but have, in fact, developed 
mechanisms for the advantageous use of free radicals. Important physiological functions 
that involve free radicals or their derivatives include the following: regulation of vascular 
tone, sensing of oxygen tension and regulation of functions that are controlled by oxygen 
concentration, enhancement of signal transduction from various membrane receptors 
including the antigen receptor of lymphocytes, and oxidative stress responses that ensure 
the maintenance of redox homeostasis (Droge, 2002).  
The field of redox regulation is also receiving growing attention from clinical colleagues in 
view of the role that oxidative stress has been found to play in numerous disease conditions. 
These pathological conditions demonstrate the biological relevance of redox regulation. The 
delicate balance between the advantageous and detrimental effects of free radicals is clearly 
an important aspect of life. The science of biological “redox regulation” is a rapidly growing 
field of research that has impact on diverse disciplines including physiology, cell biology, 
and clinical medicine (Droge, 2002). 
3.2 Biomarkers of oxidative stress 
Measuring biomarkers of oxidative stress is an essential step toward better understanding 
the pathogenesis and developing treatments for diabetic. There are several approaches that 
may be adopted, including measurements of the depletion of antioxidant reserves, changes 
in the activities of antioxidant enzymes, free radical production, and presence of protein, 
lipid, and DNA free radical adducts. For the purposes of clinical assessment, measurements 
of end products of free radical attack may be the most reliable determination of the 
occurrence of oxidative stress because enzyme activities and cellular antioxidants are likely 
to display transient changes. The enzymes responsible for detoxifying free radicals or 
regenerating antioxidant molecules can provide an indication of the stress level experienced 
in a cell or tissue. These enzymes are usually measured by in vitro activity assays, although 
changes in transcription can also provide evidence of cell stress. In long-term diabetes, 
catalase, GSH reductase, GSH peroxidase, and SOD decrease in complication-prone tissue 
(Vincent et al., 2004).  
3.3 Oxidative stress and disease 
There is a growing awareness that oxidative stress plays a role in various clinical conditions. 
Malignant diseases, diabetes, atherosclerosis, chronic inflammation, human immunodeficiency 
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virus (HIV) infection, ischemia reperfusion injury, and sleep apnea are important examples. 
These diseases fall into two major categories. In the first category, diabetes mellitus and cancer 
show commonly a pro-oxidative shift in the systemic thiol/disulfide redox state and impaired 
glucose clearance, suggesting that skeletal muscle mitochondria may be the major site of 
elevated reactive oxygen species (ROS) production. These conditions may be referred to as 
“mitochondrial oxidative stress.” Without therapeutic intervention these conditions lead to 
massive skeletal muscle wasting, reminiscent of aging-related wasting. The second category 
may be referred to as “inflammatory oxidative conditions” because it is typically associated 
with an excessive stimulation of NAD(P)H oxidase activity by cytokines or other agents. In 
this case increased ROS levels or changes in intracellular glutathione levels are often associated 
with pathological changes indicative of a dysregulation of signal cascades and/or gene 
expression, exemplified by altered expression of cell adhesion molecules (Droge, 2002). 
3.4 Oxidative stress and diabetes 
Increased oxidative stress is widely accepted as a major role player in both development and 
progression of diabetes (Maritim et al, 2002). Figure 1 summarizes the relationship between 
oxidative stress, development of diabetes and resulting complications. 
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Fig. 1.Overnutrition leads to oxidative stress which in turn results in diabetes and its 
complications (FFA: Free Fatty Acids, IGT: Impaired Glucose Tolerance, CVD: 
Cardiovascular Disease) 
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To better understand the role of tea antioxidants in either preventing diabetes or reducing 
its complications, one must first know the mechanisms through which oxidative stress 
contributes to the development of this chronic disease and disorders following it. Some 
evidence on how tea antioxidants, in particular, can prevent diabetes development and its 
progression will be presented next.  
As mentioned previously, type1 diabetes mellitus which is less prevalent than type 2 is a 
genetic autoimmune disorder affecting the islet cells leading to insulin deficiency and thus 
hyperglycemia. Type 2 diabetes however is a multi-factorial disease. Insulin resistance most 
often precedes the onset of this type by many years and can be caused by acquired factors. 
Elevations in glucose and free fatty acids have been shown to induce oxidative stress which in 
turn can play a key role in causing insulin resistance and ǃ-cell dysfunction (Evans et al., 2002). 
One most favored hypothesis on how hyperglycemia and elevated free fatty acids (FFA) can 
lead to oxidative stress is that as energy intake exceeds energy expenditure, generation of 
excess mitochondrial NADH (mNADH) and the level of reactive oxygen species (ROS) is 
increased due to the greater activity of citric acid cycle, induced by the abundance of 
substrates. Reducing ROS formation or increasing its removal is the way through which 
cells can protect themselves. The mechanism of preventing excessive mNADH generation 
may be inhibiting insulin-stimulated nutrient uptake and preventing the entrance of 
pyruvate and fatty acids into the mitochondria. Either of glucose or FFA enters the citric 
acid cycle after being converted to acetyl-CoA which then combines with oxaloacetate to 
form citrate. Greater availability of substrates will result in greater production of mNADH 
which is beyond the capability of oxidative phosphorylation to dissipate it all, leading to 
increased mitochondrial proton gradient. Thus single electrons are transferred to molecular 
oxygen forming free radicals, especially superoxide anion.  
One way the cells can reduce free radical generation is inhibition of FFA oxidation. This will 
increase intracellular FFA which in turn leads to reduced GLUT4 translocation to the plasma 
membrane resulting in resistance to insulin-stimulated glucose uptake in muscle and 
adipose tissue. In vitro studies have shown that antioxidants may have role in reducing 
insulin resistance (Ceriello et al., 2004). 
Chronic exposure to abnormally high levels of glucose and FFA leads to toxic effect on ǃ-
cells of pancreas. Furthermore as aforementioned, hyperglycemia and high levels of FFA 
leads to increased oxidative stress. ß-cells are particularly susceptible to the damages 
inflicted by oxidative stress; since they are low in free radical quenching enzymes such as 
catalase, glutathione peroxidase and superoxide dismutase. ß-cells are responsible for the 
sensing glucose and secreting appropriate amount of insulin in response to glucose boots. 
This process is pretty complex, but the critical significance of mitochondrial glucose 
metabolism in linking stimulus to secretion is well established. This is one reason that 
oxidative stress can blunt insulin secretion due to its ability to damage mitochondria (Evans 
et al., 2003; Robertson et al., 2004). 
Chronic oxidative stress can also affect insulin gene expression. At least two critical proteins 
that activate the insulin promoter are involved in defects in insulin gene expression. One is 
PDX-1 and the other is RIPE-3b1 activator recently identified as MafA. Glucose toxicity and 
lipotoxicity both of which lead to increased oxidative stress have been shown to leave 
deleterious effects on islet cells (Robertson, 2004).  
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Apoptosis is one other way through which oxidative stress can cause beta-cell dysfunction. 
There is some evidence that NF-κB is in part responsible for the induction of apoptosis in ǃ 
cells; NF-κB production is stimulated by oxidative stress (Evans et al., 2002; Robertson, 
2004). 
Uncoupling proteins (UCP) are carriers expressed in the mitochondrial inner membrane 
that uncouple oxygen consumption by the respiratory chain from ATP synthesis and can 
play a significant role in diabetes. These proteins can control ROS production in the 
mitochondria. UCP2 and UCP3 are expressed in adipose tissue and skeletal muscles, the 
tissues important for thermogenesis and substrate oxidation. Elevated expression of UCP2 
has been shown to exert negative regulation of ǃ-cell insulin secretion and contribute to 
the impairment of ǃ-cell function. UCP3 level has been reported to be decreased in 
diabetic patients and is assumed to facilitate fatty acid oxidation and minimize ROS 
production (Maiese et al., 2007).  
As mentioned previously, hyperglycemia increases peroxide generation in mitochondria 
which then through many different routes results in endothelial dysfunction and other 
diabetic complications in the end. Figure 2 illustrates how oxidative stress induced by 
hyperglycemia leads to the downstream events.   
Superoxide overproduction decreases eNOS activity, but increases iNOS expression through 
NF-κB and protein kinase C (PKC); the final effect is greater NO generation and strong 
oxidant peroxynitrite which in turn produces in iNOS and eNOS, an uncoupled state 
resulting in the production of superoxide rather than NO, and damages DNA. DNA 
damage is necessary for the activation of the nuclear enzyme poly (ADP-ribose) polymerase 
(PARP). This reduces the intracellular concentration of NAD+ which it uses as a substrate. 
The rate of glycolysis, electron transport and ATP formation reduces as a result of decreased 
NAD+ and an ADP-ribosylation of the GAPDH (glyceraldehydes 3-phosphate 
dehydrogenase) occurs. This process results in acute endothelial dysfunction in diabetic 
blood vessels, which contributes to the development of diabetic complications. NF-κB 
activation also induces a proinflammatory conditions and overexpression of the adhesion 
molecules overexpression. All these alterations end in the diabetic complications, and 
cardiovascular disorders.     
NF-κB, one major intracellular target of hyperglycemia and oxidative stress which can be 
activated by a number of stimuli including hyperglycemia, elevated FFA, ROS, TNF-ǂ, IL-
1ǃ, and other proinflammatory cytokines, AGE (advanced glycation end product)-binding 
to RAGE (receptor for AGE), DNA damage, viral infection and UV irradiation, regulates the 
expression of a large number of genes, including growth factors (vascular endothelial 
growth factor (VEGF), proinflammatory cytokines like TNF-ǂ and IL-1ǃ, RAGE, adhesion 
molecules like vascular cell adhesion molecule-1, and many others). 
VEGF has been identified as a primary initiator of proliferative diabetic retinopathy and as a 
potential mediator of nonproliferative retinopathy. It is also involved in the development of 
nephropathy and neuropathy. Thus VEGF seems to play an important role in the etiology of 
several complications of diabetes (Ishii et al., 2001; Evans et al., 2002; Esposito et al., 2002; 
Ceriello, 2003; Ceriello, 2006; Negrean et al., 2007) 
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Fig. 2. Hyperglycemia results in endothelial dysfunction and diabetic complications through 
causing oxidative stress 
3.5 Oxidative stress and antioxidants 
Several free radical species are normally produced in the body to perform specific functions. 
O2-., H2O2 and NO are three free radical reactive oxygen species (ROS) that are essential for 
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normal physiology, but are also believed to accelerate the process of aging and to mediate 
cellular degeneration in disease states. These agents together produce highly active singlet 
oxygen, hydroxyl radicals, and peroxynitrite that can attack proteins, lipids, and DNA. 
Antioxidants are defined as any compound that can donate at least one hydrogen atom to a 
free radical, resulting in the termination of radical chain reactions. An alternative type of 
antioxidant is defined by its ability to prevent the initiation of a free radical chain reaction 
rather than to terminate them. This latter type of antioxidant is usually dependent upon the 
ability to bind metal ions and includes ceruloplasmin, transferrin and albumin. Cells must 
maintain the levels of antioxidants, often defined as antioxidant potential, through dietary 
uptake or de novo synthesis. Excess production of free radicals can reduce the intracellular 
antioxidants, resulting in oxidative stress. In brief, acute hyperglycemic episodes such as an 
oral glucose tolerance test or a meal can decrease the antioxidant capacity of plasma in both 
normal and diabetic subjects and increase oxidative stress in diabetic patients. As a type 2 
diabetic patient ages, increased basal levels of free radical production and decreased 
antioxidants are even further intensified by elevated plasma glucose. Analysis of individual 
vitamin and enzyme components of the antioxidant system in man reveals significant 
changes in diabetes. The levels of vitamins A and E and catalase activity are decreased in 
both type 1 and 2 patients compared with controls. Whereas GSH-metabolizing enzymes are 
decreased in type 1 but not type 2 patients, SOD activity is lower in type 2 but not type 1 
(Vincent et al., 2004). 
4. Tea 
The scientific name given to tea, in the first volume of the book "Species Plantarum" by 
Carl Linnaeus, was "Thea Sinensis"; but in the second volume of the very book, the tea 
tree is addressed as "Camelia". Later in 1762, Linnaeus assuming black and green tea to be 
obtained from two different shrubs, chose the names "Thea bohea" and "Thea vividis" for 
black and green tea respectively. Now it is revealed that it is "Thea bohea" from which, 
both black and green tea are attained. Also the scientists have merged the two genuses 
"Camelia" and "Thea". Today the international scientific expression for tea is "Camelia 
Sinensis (L) O.kuntze", Camelia and Sinensis indicating the genus and the variety 
respectively, (L) regarding Linneaus, the first botanist to give tea a scientific name and 
O.kuntze being the one who combined the names used for black and green tea. Camelia 
Sinensis is an evergreen plant which can grow into a tree of up to 30 meters if left 
undisturbed; but cultivated plants usually have a height around 50-70 centimeters (Hara, 
2001; Moxham, 2009).  
4.1 Historical background 
It may always remain in mist, when tea first stepped into man's life. General consensus 
attributes the birth of the tea bush to the area we now call eastern China. But the discovery 
of a tea bush deep in Assam, India with leaves much larger than the Chinese one, caused 
controversy, as far as it concerns the birthplace of Camelia Sinensis. Today it is assumed that 
the tea bush was first found in the southwestern China, centered in the Yunnan district 
(Hara, 2001). Tea was first carried westwards during 5th century by Turkish traders (Alkan et 
al., 2009). 
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The question as to when the man first consumed tea is unanswered as well. According to 
Chinese mythology, it was the emperor Shen Nung who discovered tea for the first time in 
2737 B.C.; but this is not in consistence with the first credible documentary reference on tea 
which was made in 59 B.C. (Hara, 2001; Gupta et al., 2002). 
It is probable that our forbears used tea in response to their instinctive seek for a material to 
calm them; because tea is rich in an alkaloid called caffeine which acts as an opioid in the 
nervous system, relaxing the consumer. 
On tropical and subtropical climates and regions on which precipitation is coordinate 
according to months and where summers and winters are lukewarm, tea production is 
realized. Sour and humid land structure is crucial to growing tea as well (Alkan et al., 2009). 
Based on the data generated by the food and agriculture organization (FAO) of the united 
nations as of January 2010, China was the leading country in tea production in 2006, 2007 and 
2008,  followed by India, Kenya, Sri Lanka, Turkey, Vietnam and Indonesia. Other main tea 
producing countries are Japan, Argentina, Iran, Bangladesh, Malawi and Uganda Figure (3). 
The global tea production growth rate in 2006 extended more than 3% to reach an estimated 
3.6 million tons, China, Viet Nam and India being the main counties to have contributed to this 
rise. It is predicted that world black tea production rate decreases in the current century, due 
to slowing down of production growth in Africa. India followed by Kenya and Sri Lanka are 
projected to be the main contributors to black tea production by 2017 which is estimated to 
reach 3.1 million tons (http://en.wikipedia.org/wiki/Tea; Hicks, 2009). 
 
Fig. 3. The tea producing regions in 2007 
www.intechopen.com
 
Oxidative Stress – Environmental Induction and Dietary Antioxidants 
 
234 
4.2 Chemical compounds in tea 
In contrast to the history of tea drinking which is ancient, the chemical components of tea 
have quite recently been investigated. Teas acquired from different regions may have 
different chemical components in different amounts. The agents found in tea are classified 
as primary or subordinate (Table 1): 
Primary components subordinate components 
Alkaloids (xanthines) Mineral acids 
Polyphenols Organic acids 
Vitamins Proteins 
Enzymes Pectin 
Volatile oils (essence) 
Lignans 
Amino acids 
Table 1. The classification of primary and subordinate tea agents  
The quality of a tea is related to its content of alkaloids (caffeine), flavonoids (catechins), 
phenolic acids (gallic acid, coumaric acid, caffeic acid and chlorogenic acid) and volatile oils 
(essences) (Table 1) (Bendini et al., 1998; Wang et al., 2000).    
Alkaloids: In 1827, caffeine which is present in a few other plants was discovered in tea. By 
then it was given the name "Theine" which was dropped as its structure was proven to be 
exactly the same as that of caffeine, in 1820. The mean content of caffeine in tea ranges 
between 1.9 and 4.5 and is negatively correlated with the age of the leaves (Wanger et al., 
1996; Hara, 2001).  
Polyphenols: Theanine and flavonoids (catechins in particular) are the main polyphenols 
found in tea constituting 30% of its agents.  
Theanine: A unique substance in tea is theanine which is a kind of amino acid comprising 
more than half of the amino acids present in tea. It has an "umami" or sweet taste and 
constitutes 2% of tea (Hara, 2001).   
Flavonoids: Flavanols and their derivatives including flavan-3-ols (catechins and 
epicatechins) and flavonols are the chief flavonoids in tea. Under mild oxidation, flavan 3-4 
diol derivatives of flavonoids are converted to catechins and its isomers. Green tea is a great 
source of catechins and thus exerts antioxidant properties. These catechins change into 
oligomeric quinones under the fermentation process of black tea which reduces its 
antioxidant capacity by 2-6 times in comparison to the green tea (Hara, 2001). Each gram of 
green tea contains 123.8- 206.3 milligrams of catechins which is 10-30 percent of the dry 
weight of the green leaves. In black tea, 79.3 milligrams of catechins is found in one gram 
(Wang et al., 2000; Bronner et al., 1998; Keys, 1976). All catechins have 2 asymmetric carbons, 
thus there are four isomers of them: catechin (C)(+), catechin gallate (CG)(-), gallocatechin 
(GC) and gallocatechin gallate (GCG) (-). The number of hydroxyl group on the B ring 
differs for the derivatives of catechins. Like catechins, epicatechins are the monomers of the 
condensed thanines, are derived from flavan 3-4 diols and have two asymmetric carbons in 
their structure resulting in four isomers. These isomers include: epicatechin (EC)(-), 
epigallocatechin (EGC)(-), Epicatechin gallate (ECG)(-) and epigallocatechin gallate 
(EGCG)(-). Catechins and epicatechins are the major polyphenols found particularly in 
green tea (Figure 4).  
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Epigallocatechin gallate (EGCG), being the greatest in amount in tea compared to the other 
catechins, makes up to 50% of its catechins. EGCG is more abundant in green tea and its 
quantity is negatively correlated with the age of the leaves (Hara, 2001; Leung et al., 2001). 
Vitamins and minerals: Vitamin C was discovered in 1924 in fresh tea leaves. Tea is a great 
source of fluoride too (Hara, 2001). Other vitamins and minerals may be present in tea at 
little amounts as well. 
Enzymes: The enzymes in tea which catalyze the oxidation processes are called Thease. 
During fermentation in which tea pectins are demetylated, polyphenolic compounds are 
decomposed which as a result of the quinone appearance, turn into some colorful agents 
including theaflavin and thearubigin, both of which are plentiful in black tea (Figure 4) 
(Hara, 2001; Leung et al., 2001; Cadenas, 2002). 
Volatile oils: More than 600 volatile agents have been established in tea, most of which have a 
yellow color and a characteristic scent. Linalool is the main essence in tea, other of lesser 
importance ones being dihydroactinide iolido paravinile phenol, hexenol, hexenal, 
aldehydes, phenyl ethyl alcohols, phenols and geraniols (Hara, 2001). 
 
Fig. 4. Major polyphenols in green and black tea 
Based upon the preparation method, the degree to which it is fermented and the steps it goes 
under during the production, different types of tea consumed all over the world are classified 
into at least six categories (Figure 5). The less processed the tea, the greater the polyphenols 
content will be, which the extent of oxidation accounts for (Santana-Rios et al., 2001). 
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1. White tea: White tea is manufactured only from the buds or first leaves of C.sinensis. It 
is the least processed type of tea and is simply steamed and dried without a prior 
withering stage; therefore the concentrations of EGCG and also methylxanthines (like 
caffeine) are enriched in white tea compared with green and black tea.  
2. Yellow tea: It usually implies a special tea processed in a similar way to green tea; but 
the drying process takes place at a slower rate. The damp tea leaves are allowed to sit 
and yellow. Its taste resembles that of green and white teas. 
3. Green tea: To manufacture green tea, first the fresh leaves are steamed, then primary 
drying-rolling, rolling, secondary drying-rolling, final drying-rolling and at last drying 
are performed. No fermentation takes place in this type of tea. 
4. Oolong tea: Fresh leaves undergo solar withering at the first step, indoor withering and 
rolling, pan firing, rolling, mass breaking and drying are the steps to be taken, to 
produce oolong tea. In this kind of tea, partial fermentation occurs after the rolling. 
5. Black tea: The manufacturing process for black tea includes withering of fresh leaves, 
rolling, fermenting and drying. Thorough fermentation is done in black tea. 
6. Pu-erh: Pu-erh is applied to old tea with extreme fermentation in it (Hara, 2001; 
Santana-Rios et al., 2001; Kuo et al., 2005; Lin et al., 2006; Sohle et al. 2009; Wang et al., 
2008; http://en.wikipedia.org/wiki/Tea; http://www.tea-of-chinese.com). 
 
Fig. 5. The production of different types of tea 
4.3 Tea and diseases 
Tea being a great source of phytoestrogens and fluoride, both of which play a major role in 
bone health, is reported to prevent osteoporosis and the lower prevalence of the very 
disease in Japanese postmenopausal women in comparison with American and European 
ones, is attributed to greater amounts of tea consumed by Japanese (Adlercreutz et al., 1991; 
Adlercreutz et al., 1992; Johnell et al., 1995; Kanis et al., 1999). 
Tea due to its content of polyphenols has been found to be effective in preventing many 
types of cancer including liver, small intestine and lung. Polyphenols increase the catalytic 
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activity of enzymes involved in glutathione and quinone synthesis and remove the free 
radicals of hydrogen peroxide and superoxide anions. Tea consumption also inhibits 
metastasis of human lymphoid leukemia cells through stimulation of apoptosis and 
hindrance of platelet aggregation (Bronner et al., 1998; Dulluge et al., 1998; Integrative 
Medicine, 2000; Springhouse, 2001). 
Studies have shown that tea is beneficial in delaying cardiovascular disorders. Some 
mechanisms described are: inhibiting the progression of atherosclerosis and thrombosis, 
preventing hypertension by either exerting effects similar to those of beta-blockers or 
stimulating diuresis, decreasing postprandial blood cholesterol and triglycerides, inhibition 
of LDL oxidation and improvement of endothelial function. Also, decreasing the activity of 
lipoxygenase enzymes and stimulating central nervous system, tea can improve heart 
muscle function, circulation in coronary vessels and respiration (Yamamoto, 1997; Robbers 
et al., 1999; Leung et al., 2001; Alipoor et al., 2008). Hypertension is another disorder which 
can be corrected by tea and its polyphenols. This has been attributed to its role in regulating 
renin-angiotensin system (RAS) and improving endothelial function (Adlercreutz, 1991). 
Since tea and its polyphenols have been observed to reduce digestion and absorption of fats 
and carbohydrates, and due to their role in controlling food intake, increasing energy 
expenditure, modifying the activity of liver, muscle, gastrointestinal tract and fat cells, 
weight loss and prevention of diabetes mellitus could be one advantage of drinking 
appropriate amounts of tea (Watanabe et al., 1998; Kuo et al., 2005; Ynng et al., 2006). How 
tea can play a major role in prevention and treatment of many complications of diabetes 
mellitus will be presented more precisely in the next section. 
Other disorders which tea can play a role in prevention or treatment of, includes 
inflammation, migraine, nausea, diarrhea, maldigestion, sore throat, depression, prostatitis, 
hemochromatosis, neurodegenerative diseases like Parkinson and Alzheimer, cataract, 
dental carries and some viral and bacterial infections including influenza, polio, herpes 
simplex and AIDS (Duke, 1985; Robertson et al., 1991; Hertog et al., 1993; Cummings et al., 
1995; Tavani et al., 1996; Van Het Hof et al., 1997; Integrative Medicine, 2000; Mills et al., 
2000; McKay et al., 2002; Wright, 2005; Kao et al., 2006; Sasso et al., 2006; Alipoor et al., 2011). 
4.4 Tea antioxidants and oxidative stress 
There is a considerable amount of evidence indicating the benefits of tea consumption to 
prevent diabetes and reducing its resulting complications. The less processed the tea, the 
more its antioxidant content; which may explain why most studies have been conducted 
using green tea as the supplement. Recently, white tea which is not fermented either, has 
been studied for its impact on diabetes too. Some ways through which tea and its bioactive 
compounds affect diabetes are not related to the antioxidant properties of tea, thus not 
within the scope of this chapter; and won't be discussed here. 
Many studies have shown that different types of tea are potentially effective in reducing 
oxidative stress and related diseases. Attempts have been made to manufacture products 
containing tea bioactive compounds for prevention and treatment of mentioned diseases. In 
order to design such product, the effective compounds of tea and the safe dose of them must 
be first identified. For instance, EGCG has been shown to act as a prooxidant when 
administered in high doses and lead to apoptosis. Furthermore compounds other than 
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catechins may exert the desired effects as well (Liao et al., 2001; Mandel et al., 2004; Kao et al., 
2006). To determine the very compounds acting as antioxidants in black tea, Alipoor et al., 
(2009) performed a study in which diabetic rats were supplemented total extract of black tea 
and its fractions. Total extract and fractions were attained by hydromethanol method and solid 
phase extraction using Sep-Pak respectively. Results of this study showed that injection of total 
extract and 20% fraction of black tea decreased malondialdehyde (MDA) and increased total 
antioxidant, Super oxide Dismotase (SOD), Glutathione Peroxides (GPX) and Glutathione in 
diabetic rats. To find out the major substances in the 20% fraction, Analytical HPLC, 
Preparative HPLC (High Performance Liquid Chromatography) and NMR (Nuclear Magnetic 
Resonance) (CNMR and HNMR) were employed. Caffeine, Epicatechin Gallate, Quercetin and 
Kampferol were the main compounds capable of combating oxiadative stress, to be 
determined in 20% fraction of tea (Figure 6) (Alipoor et al., 2010). 
N
N N
N
O
O
CH
3
CH
3
CH
3
O
O
OH
OH
OH
OH
OH
OH
O
OH
O
O
R
OH
OH
OH
O
O
OH
OH
OH
CH
2
OH
3            R=OH
4            R=H
1 2Caffeine
Epicatechin Gallate
R: OH Quercetin
R: H Kampferol
 
Fig. 6. Major antioxidants in 20% fraction of black tea 
Caffeine is a strong antioxidant and its activity being equal to that of glutathione and 
exceeding that of vitamin C (Devasagayam et al., 1996; Kamat et al., 2000; Nikolic et al., 2003). 
The free radical scavenging capacity of flavonoids is due to the 3', 4' dihydroxyl and 3' 
hydroxy in the ǃ ring (Amic et al., 2003). The 20% fraction of black tea has been shown to be 
more effective than the other fractions which may be explained by the high concentration of 
the aforementioned compounds in it and absence of polyphenol antagonists in the very 
extract prepared (Alipoor et al., 2009). 
Tea polyphenols have been found to induce expression of phase II enzymes and 
endogenous antioxidants that defend cells from oxidative stress. The promoter regions of 
the phase II genes contain specific DNA sequences, termed the antioxidant response 
elements (AREs) or the electrophile response elements (EREs) that are required for induction 
by chemopreventive compounds, oxidative stress or electrophiles. In an attempt to find the 
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transcription factors that bind to ARE, NF-E2-related factor 2 (Nrf2) was identified (Zhang, 
2006). Nrf2 binds to Kelch-like ECH-associated protein 1 (Keap1) under nonstressed 
conditions. Keap1 in complex with cullin3, Roc1 and E2 proteins provides ubiquitination 
followed by proteasomal degradation. When oxidative stress occurs, oxidation of Keap1 
leads to inability to bind Nrf2 protein by forming intramolecular disulfide bonds. Then Nrf2 
migrates into the nucleus and binds a protein of Maf family (like sMaf) and CBP/p. This 
complex is formed on ARE promoter region of certain genes leading to transcription 
activation. Phosphorylation of by protein kinases which may be activated by oxidants is one 
way to provide Nrf2 migration in nucleus (Lushchak, 2011). 
4.4.1 Evidence from animal studies 
Tea polyphenols have been demonstrated to improve lipid profile in diabetic and 
nondiabetic models. In this section, we follow the antioxidant properties of tea. Improved 
glucose tolerance and increased plasma insulin concentrations by tea, have been found in 
some studies which may be, in part, explained by the effect of tea antioxidants on insulin 
resistance and ǃ-cell function. EGCG has also been shown to suppress cytokine-induced ǃ-
cell damage; this may also contribute to glucose lowering effect of tea (Gomes et al., 1995; 
Han et al., 1999; Kao et al., 2000; Sabu et al., 2002; Wu et al., 2004; Tsuneki et al., 2004; Babu et 
al., 2006; Wolfram et al., 2006; Igarashi et al., 2007; Badawoud et al., 2007; Ostad Rahimi et al., 
2007; Potenza et al., 2007).     
Lipid peroxidation is an indicator of oxidative stress and plays major role in development of 
some complications of diabetes. Animal studies have shown that green tea administration 
can reduce lipid peroxidation in diabetic animals (Yamaguchi et al., 1991; Tijburg et al., 1997; 
Vinson et al., 1998; Miura et al., 2001; Guleria et al., 2002; Kasaoka et al., 2002; Nakagawa et 
al., 2002; Liuji et al., 2002; Sabu et al., 2002; Skrzydlewska et al., 2002; Babu et al., 2006). Black 
tea has been reported to be an efficient reducer of peroxidation of lipoproteins as well 
(Tijburg et al., 1997; Vinson et al., 1998; Sur-Altiner et al., 2000; Yokozawa et al., 2002; Vinson 
et al., 2005; Alipoor et al., 2008). Some studies have investigated the effects of purified tea 
polyphenols and drawn similar results (Quine et al., 2005; Yamabe et al., 2006). 
MDA is another important indicator of oxidative stress that is usually measured in diabetics. 
Based on the results of studies, tea seems to affect this factor too and reduce its plasma 
concentration (Durate et al., 2001; Skrzydlewska et al., 2002; Chander et al., 2003; Sürmen-Gür 
et al., 2006; Alipoor et al., 2009). 
The activity of antioxidant enzymes such as catalase, superoxide dismutase, glutathione 
reductase and glutathione peroxidase has been shown to increase by supplementation of tea 
or its polyphenols as well. Actually some enzymes showed greater activity after the very 
supplementation in one study but not the other which seems to be due to different doses of 
supplementation, design and duration of the study (Khan et al., 1992; Lin et al., 1998; Durate 
et al., 2001; Sabu et al., 2002; Skrzydlewska et al., 2002; Chander et al., 2003; Kuo et al., 2005; 
Babu et al., 2006; Alipoor et al., 2009).         
Glutathione is another parameter which has been measured in some studies and seems to 
increase in diabetics receiving tea intervention (Sohn et al., 1994; Lin et al., 1998; Durate et al., 
2001; Sabu et al., 2002; Skrzydlewska et al., 2002; Babu et al., 2006; Alipoor et al., 2009). 
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4.4.2 Evidence from human studies       
Human studies are not as conclusive as animal ones. There is some evidence that in countries 
with higher tea consumption like Japan, diabetes is less prevalent (Iso et al., 2006). Some 
studies have shown a negative correlation between tea consumption and heart disorders and 
its consequent death (Stensvold et al., 1992; Imai et al., 1995; Duffy et al., 2001; Geleijnse et al., 
2002; Hodgson et al., 2002; Hakim et al., 2003) which can be, in large part, attributed to the 
effects of tea on endothelial function through reducing oxidative stress; but there have been 
studies in which no relation was observed (Brown et al., 1993; Sesso et al., 2003) 
Tea consumption decreased lipid peroxidation in some clinical trials (Klaunig et al., 1999), 
but was not as effective in the others (Van Het Hof et al., 1999; Hodgson et al., 2000; Rumpler 
et al., 2001; Hodgson et al., 2002). 
Results for malondialdehyde were inconsistent as well: some investigations indicating a 
negative relation between tea and MDA (Freese et al., 1999; Hirano-Ohmori et al., 2005; Nagao 
et al., 2005), others showing no significant relationship (Rumpler et al., 2001; Davis et al., 2003). 
The activity of antioxidant enzymes or oxidative status of the serum were improved by tea 
intervention in some studies (Serafini et al., 1996; Nakagawa et al., 1999; Leenen et al., 2000; 
Sung et al., 2000; Young et al., 2002), but remained unchanged in the others (Van Het Hof et 
al., 1997; Princen et al., 1998; Freese et al., 1999; Miura et al., 2000; Davis et al., 2003; Henning 
et al., 2004; Davis et al., 2005).         
As reviewed above there is some evidence that tea and its fractions can act against 
development of diabetes and its complications but some studies have shown insignificant 
results. More detailed and precise clinical trials are essential to better understanding of tea's 
role in diabetes through its capacity to reduce oxidative stress.  
Although animal studies provide great deal of evidence on usefulness of tea and its 
polyphenols against oxidative stress and its consequences in diabetes, human studies are 
not conclusive and limited research has not generally revealed significant decreases in 
biomarkers of in vivo oxidative damage. Far wider genetic variations in the response of 
humans to oxidative stress in comparison with animals may be one important factor 
obscuring small changes in biomarkers induced by tea and its polyphenols. Another reason 
may be that, though the dose of tea and its effective compounds used in animal and human 
studies do not differ much. Much higher doses relative to body weight is used in animal 
studies (Frei et al., 2003).   
5. Conclusion and future trends 
Oxidative stress has been showed to play an important role in initiation and progression 
of diabetes and its accompanying complications. Thus to prevent the very consequences 
of oxidative stress, it seems logical to take the necessary steps to reduce it. Antioxidants 
have been reported to be effective in fulfilling this goal. Tea is a great source of a group of 
antioxidants so called flavonoids. Animal studies have been done to detect which 
compounds in tea are responsible for its effects on oxidative stress but human studies are 
lacking. 
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Animal studies have strongly supported the idea of tea being an efficient suppressor of 
oxidative stress in diabetic animals but human studies have faced inconsistency which may 
be rooted in factors like the design and time course of the study, the dose supplemented, the 
oxidative status of the subjects at baseline, the type of the tea studied, the stage of the 
disease, confounding factors not considered in some studies. It is recommended that well 
designed controlled clinical trials be done taking into account all the factors affecting the 
oxidative status of the patients and using sensitive and specific indicators of oxidative stress. 
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